A Phase III Study of Radical Radiotherapy with or without Gemcitabine in Patients with T1-2 N0-1 M0 Non-Small Cell Lung Cancer.

Trial Profile

A Phase III Study of Radical Radiotherapy with or without Gemcitabine in Patients with T1-2 N0-1 M0 Non-Small Cell Lung Cancer.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 16 Dec 2015

At a glance

  • Drugs Gemcitabine (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms GRIN
  • Most Recent Events

    • 01 Sep 2012 Status changed from completed to discontinued, as reported in Lung Cancer.
    • 01 Sep 2012 Results published in the Lung Cancer.
    • 10 Jun 2010 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top